Madrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH

Press/Media

Period4 Oct 2021

Media coverage

1

Media coverage

  • TitleMadrigal Pharmaceuticals Announces Support of Fatty Liver Foundation's Screening Fund to Improve Diagnosis and Staging of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date4/10/21
    PersonsMeena Bansal